|
|
 |
Home |
|
|
|
About |
|
|
|
Products |
|
|
|
Research |
|
|
|
Markets |
|
|
|
Contact |
|
|
|
News |
|
|
Company News
March, 2010 - Dr. Deepak Khuntia and Dr. James Cleary at the University of Wisconsin Carbone Cancer Center open patient enrollment in a Phase I/II clinical trial to determine the safety and efficacy in oral mucositis prevention of topically applied vasoconstrictor in patients receiving radiotherapy for head and neck cancer.
June, 2009 - Dr. James Cleary and Dr. Deepak Khuntia at the University of Wisconsin Carbone Cancer Center begin patient enrollment in a Phase I/II clinical trial to determine the safety and efficacy in radiodermatitis prevention of topically applied vasoconstrictor in patients receiving radiotherapy to treat bone metastases.
June 29, 2009 - Milwaukee Journal Sentinel does interview of acting CEO (Paul Weiss) about opened clinical trials and ProCertus product development.
June 30, 2009 - ProCertus BioPharm, Inc. closes $2.1 Million Series A Financing led by Novartis Venture Fund and Venture Investors, LLC.
June, 2009 - Series A investment round covered by Wisconsin State Journal, The Business Journal and other publications.
May, 2008 - Investigators (Dr. James Cleary et al.) at University of Wisconsin Carbone Cancer Center complete Phase I clinical study of DermX/ProDermaCel™ technology. Normal subjects receiving six week topical application of DermX formulation demonstrated: i) no significant topical or systemic toxicities over the six week drug course at any of the scheduled doses, ii) successful compliance with the topical drug application schedule that involved five applications per week x six weeks, and iii) successful induction of the scored skin endpoint that predicted complete radioprotection in animal models of radiodermatitis.
May, 2007 - Series A investment round covered by Wisconsin State Journal, Capital Times, and other publications
May 14, 2007 - Wall Street Reporter does web interview of CSO (Fahl) about ProCertus product development
May 10, 2007 - ProCertus BioPharm, Inc. Closes $2.3 Million Series A Financing Led by Venture Investors LLC
Spring '07 - ProCertus is featured Company in Research Digest